Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New sleep therapy could help Night-Shift healthcare workers finally rest

NCT ID NCT06827626

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a special type of talk therapy for insomnia (CBT-I) that is customized for shift workers can improve sleep, mental health, and quality of life. About 84 healthcare workers who work rotating shifts including nights will either receive this tailored therapy or a brief sleep hygiene session. Researchers will track their sleep and well-being for up to 6 months after treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 84 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * age 18-65 years * working in social and heath care sector * 3- or 2-shift work including night shift at least once per month * full time or nearly full time shift work (75-100 %) * Insomnia Severity Index score \> 10 * duration of insomnia symptoms at least 3 months * shift work continuing for at least the next year * sufficient Finnish language skills (coaching materials in Finnish only) Exclusion Criteria: * non-assessed or untreated clinically significant somatic or mental symptoms or illnesses or other sleep disorders that could explain current insomnia symptoms * earlier participation to CBT-I * other ongoing or planned psychotherapeutic/psychological intervention

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Insomnia chronic are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Finnish Institute of Occupational Health

    Helsinki, Uusimaa, FI-00032, Finland

  • Joint Authority HUS

    Helsinki, Uusimaa, FI-00029, Finland

  • Terveystalo Oyj

    Helsinki, Uusima, FI-00100, Finland

  • The Wellbeing Services County of South Ostrobotnia and TT Botnia Oy

    Seinäjoki, Finland

More trials for these conditions

Other studies related to the condition(s) this trial covers.